best health software glp-1 alerts 2025 Prescriptions Quadruple Since 2021 Alongside Decline In Obesity Low awareness of GLP-1s globally,

Although NAT is very beneficial due to the requirement of higher investment for its implementation, low-resources countries like India are not able to make it mandatory for screening of blood for TTIs

Limitations Adverse Effects Although GLP1-RA help improve glycemic control, promote weight loss, and reduce cardiovascular events, there are several limitations to its use

Clinical trials demonstrate unprecedented weight loss of up to 22.5% of body weight over 72 weeks , rivaling the outcomes of bariatric surgery, alongside a 2.02.4% reduction in HbA1c , achieving glycemic control unparalleled in current diabetes treatments ( 1, 2, 3 )

Small amounts (1 standard drink) with food are generally safe for most patients, but risks include hypoglycaemia, delayed absorption (leading to over-drinking), dehydration, and increased pancreatitis risk

Whether one is worth the wait depends on your complexity and your coverage